AMANDA ALLIE: Open Payments
NPI 1699370452 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 60 payments from 13 companies in 2025. Trend: 2023 $202 · 2024 $0 · 2025 $1,244
Food & beverage: $1,244
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $438 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $189 |
| Janssen Pharmaceuticals, Inc | 5 | $126 |
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $120 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Alkermes, Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, INVEGA SUSTENNA, FANAPT, Jornay PM, Auvelity.
Industry payments across NY — which companies pay providers there.
